Balance Sheet: Assets

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Assets are resources controlled by the company as a result of past events and from which future economic benefits are expected to flow to the entity.

UnitedHealth Group Inc., consolidated balance sheet: assets

US$ in millions

	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash and cash equivalents	25,312)	25,427)	23,365)	21,375)	16,921)
Short-term investments	3,801)	4,201)	4,546)	2,532)	2,860)
Accounts receivable, net of allowances	22,365)	21,276)	17,681)	14,216)	12,870)
Other current receivables, net of allowances	26,089)	17,694)	12,769)	13,866)	12,534)
Assets under management	—)	3,755)	4,087)	4,449)	4,076)
Prepaid expenses and other current assets	8,212)	6,084)	6,621)	5,320)	4,457)
Current assets	85,779)	78,437)	69,069)	61,758)	53,718)
Long-term investments	52,354)	47,609)	43,728)	43,114)	41,242)
Property, equipment and capitalized software, net of accumulated depreciation and amortization	10,553)	11,450)	10,128)	8,969)	8,626)
Goodwill	106,734)	103,732)	93,352)	75,795)	71,337)
Other intangible assets, net of accumulated amortization	23,268)	15,194)	14,401)	10,044)	10,856)
Other assets	19,590)	17,298)	15,027)	12,526)	11,510)
Noncurrent assets	212,499)	195,283)	176,636)	150,448)	143,571)
Total assets	298,278)	273,720)	245,705)	212,206)	197,289)

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

Cash and Cash Equivalents: Cash and cash equivalents demonstrated a steady increase from 2020 to 2023, rising from $16,921 million to $25,427 million. In 2024, the amount slightly decreased to $25,312 million, indicating a near plateau after continuous growth over four years.
Short-term Investments: Short-term investments exhibited some volatility over the five-year period. Starting at $2,860 million in 2020, the value declined to $2,532 million in 2021, then sharply increased to $4,546 million in 2022. This was followed by a decline in both 2023 and 2024 to $4,201 million and $3,801 million, respectively, suggesting fluctuations in short-term investment strategy or market conditions.
Accounts Receivable, Net of Allowances: The accounts receivable showed consistent growth across all periods, rising significantly from $12,870 million in 2020 to $22,365 million in 2024. This upward trend suggests an expanding credit sales volume or slower collection periods.
Other Current Receivables, Net of Allowances: Other current receivables initially increased from $12,534 million in 2020 to $13,866 million in 2021 but then declined to $12,769 million in 2022. However, a substantial increase occurred in 2023 and 2024, climbing to $17,694 million and $26,089 million respectively, indicating a notable rise in miscellaneous current receivables or possibly changes in recognition timing.
Assets Under Management: Assets under management fluctuated mildly, increasing slightly from $4,076 million in 2020 to $4,449 million in 2021 but declining thereafter to $3,755 million in 2023. Data for 2024 was not provided, making the recent trend unclear.
Prepaid Expenses and Other Current Assets: Prepaid expenses and other current assets showed an overall increasing trend, growing from $4,457 million in 2020 to $8,212 million in 2024, with a slight dip in 2023. This indicates an expansion in advance payments or other current asset categories.
Current Assets: Current assets consistently increased year-over-year, from $53,718 million in 2020 to $85,779 million in 2024. This steady growth reflects the combined trends in cash, receivables, prepaid expenses, and other current items, signifying strengthening liquidity or operational scale.
Long-term Investments: Long-term investments steadily increased from $41,242 million in 2020 to $52,354 million in 2024, demonstrating consistent commitment to long-term asset holdings or investment strategies.
Property, Equipment, and Capitalized Software, Net: This asset category increased from $8,626 million in 2020 to a peak of $11,450 million in 2023 before declining to $10,553 million in 2024, suggesting capital expenditures were strong until 2023 but somewhat reduced or depreciated significantly by 2024.
Goodwill: Goodwill exhibited a strong upward trajectory, rising from $71,337 million in 2020 to $106,734 million in 2024, pointing to acquisitions or intangible asset growth during the period.
Other Intangible Assets, Net: Other intangible assets increased overall, with a significant jump from $10,856 million in 2020 to $23,268 million in 2024, indicating investments in or recognition of intangible resources such as licenses or intellectual property accelerated notably after 2021.
Other Assets: Other assets steadily grew from $11,510 million in 2020 to $19,590 million in 2024, suggesting expansion or reclassification of miscellaneous asset accounts over time.
Noncurrent Assets: Noncurrent assets showed continuous growth, from $143,571 million in 2020 to $212,499 million in 2024. This increase aligns with the trends in investments, goodwill, intangible assets, and property, illustrating ongoing asset accumulation and capital investment.
Total Assets: Total assets rose consistently each year from $197,289 million in 2020 to $298,278 million in 2024. This reflects an overall growth trend in the company's asset base, supported by increases in both current and noncurrent assets.

Assets: Selected Items

Download chart

Current Assets: Selected Items

Download chart

UnitedHealth Group Inc. (NYSE:UNH)

Balance Sheet: Assets

Assets: Selected Items

Current Assets: Selected Items